Receptors, Estrogen

"Receptors, Estrogen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important.

Descriptor ID

D011960

MeSH Number(s)

D12.776.260.698.750.350

D12.776.826.750.350

D12.776.930.669.750.350

Concept/Terms

Receptors, Estrogen

Receptors, Estrogen, Type II

Estrogen Nuclear Receptor

Receptors, Estrogen, Type I

Below are MeSH descriptors whose meaning is more general than "Receptors, Estrogen".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
DNA-Binding Proteins [D12.776.260]
Receptors, Cytoplasmic and Nuclear [D12.776.260.698]
Receptors, Steroid [D12.776.260.698.750]
Receptors, Estrogen [D12.776.260.698.750.350]
Receptors, Cytoplasmic and Nuclear [D12.776.826]
Receptors, Steroid [D12.776.826.750]
Receptors, Estrogen [D12.776.826.750.350]
Transcription Factors [D12.776.930]
Receptors, Cytoplasmic and Nuclear [D12.776.930.669]
Receptors, Steroid [D12.776.930.669.750]
Receptors, Estrogen [D12.776.930.669.750.350]

Below are MeSH descriptors whose meaning is related to "Receptors, Estrogen".

Below are MeSH descriptors whose meaning is more specific than "Receptors, Estrogen".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Receptors, Estrogen" by people in Harvard Catalyst Profiles by year, and whether "Receptors, Estrogen" was a major or minor topic of these publication.

Bar chart showing 1177 publications over 31 distinct years, with a maximum of 71 publications in 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	4	4	8
1995	9	9	18
1996	5	8	13
1997	8	7	15
1998	7	8	15
1999	3	11	14
2000	11	16	27
2001	18	14	32
2002	11	13	24
2003	15	13	28
2004	20	20	40
2005	15	17	32
2006	15	29	44
2007	14	28	42
2008	20	27	47
2009	19	19	38
2010	27	32	59
2011	14	57	71
2012	22	35	57
2013	30	33	63
2014	11	34	45
2015	18	40	58
2016	28	30	58
2017	11	37	48
2018	17	29	46
2019	20	41	61
2020	20	35	55
2021	13	32	45
2022	4	33	37
2023	2	27	29
2024	0	8	8

Below are the most recent publications written about "Receptors, Estrogen" by people in Profiles.

ASO Visual Abstract: Defining the Biology of Estrogen Receptor-Low Positive Breast Cancer. Ann Surg Oncol. 2024 Apr; 31(4):2284-2285.

View in: PubMed
Ribociclib plus Endocrine Therapy in Early Breast Cancer. N Engl J Med. 2024 Mar 21; 390(12):1080-1091.

View in: PubMed
Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial. JAMA Oncol. 2024 Mar 01; 10(3):362-371.

View in: PubMed
Breast Cancer Molecular Subtyping in Practice: A Real-World Study of the APIS Breast Cancer Subtyping Assay in a Consecutive Series of Breast Core Biopsies. Int J Mol Sci. 2024 Feb 23; 25(5).

View in: PubMed
Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast Cancer. Cancer Res Commun. 2024 02 22; 4(2):496-504.

View in: PubMed
Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor-Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer. Clin Cancer Res. 2024 02 16; 30(4):754-766.

View in: PubMed
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial. JCO Precis Oncol. 2024 Feb; 8:e2300285.

View in: PubMed
Analysis of Breast Cancer Mortality in the US-1975 to 2019. JAMA. 2024 01 16; 331(3):233-241.

View in: PubMed
Defining the Biology of Estrogen Receptor-Low-Positive Breast Cancer. Ann Surg Oncol. 2024 Apr; 31(4):2244-2252.

View in: PubMed
In ER-Positive, HER2-Negative Breast Cancers, HER2 mRNA Levels Correlate Better with Clinicopathologic Features and Oncotype DX Recurrence Score than HER2 Immunohistochemistry. Lab Invest. 2024 03; 104(3):100309.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

Breast Cancer Res Treat
J Clin Oncol
Clin Cancer Res
Breast Cancer Res
J Natl Cancer Inst
Ann Oncol
Proc Natl Acad Sci U S A
Cancer Res
Ann Surg Oncol
Endocrinology